Matching trials
2,411 results
- Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with…
- Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary…
- Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Immunotherapy in Biochemically Recurrent Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy in Biochemically Recurrent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03315871).
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01570036).
- Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers: Complete Statistical AnalysisIndependent statistical analysis of Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01121939).
- Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD): Complete Statistical AnalysisIndependent statistical analysis of Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL: Complete Statistical AnalysisIndependent statistical analysis of Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial): primary endpoint results, effect estimate…
- Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combined Spinal/Epidural (CSE) Saline Duration/Spread: Complete Statistical AnalysisIndependent statistical analysis of Combined Spinal/Epidural (CSE) Saline Duration/Spread: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01062893).
- Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen: Complete Statistical AnalysisIndependent statistical analysis of Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen:…
- Combined Treatment for Alcohol-Dependent Individuals With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Combined Treatment for Alcohol-Dependent Individuals With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00262223).
- Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC: Complete Statistical AnalysisIndependent statistical analysis of Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COMETABreastIndependent statistical analysis of Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Comparison of a Drug and Placebo in the Prevention of Migraine Headaches: Complete Statistical AnalysisIndependent statistical analysis of Comparison of a Drug and Placebo in the Prevention of Migraine Headaches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02163434).
- Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients: primary endpoint results, effect…
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size…
- Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK): Complete Statistical AnalysisIndependent statistical analysis of Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer: primary endpoint results, effect estimate…
- CompassHER2Independent statistical analysis of CompassHER2 (NCT04266249), a phase 2 non-randomized trial evaluating recurrence-free survival after pre-surgery chemotherapy and targeted therapy in breast cancer.
- Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI): Complete Statistical AnalysisIndependent statistical analysis of Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01956279).
- CONCERTIndependent statistical analysis of Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk: Complete Statistical AnalysisIndependent statistical analysis of Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00861146).
- Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CONSERVAIndependent statistical analysis of Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior: Complete Statistical AnalysisIndependent statistical analysis of Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ConstellationIndependent statistical analysis of BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CONTAINIndependent statistical analysis of Inhaled Ciclesonide for Outpatients With COVID19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04435795).
- Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: Complete Statistical AnalysisIndependent statistical analysis of Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Convalescent Plasma vs. Standard Plasma for COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Convalescent Plasma vs. Standard Plasma for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04344535).
- Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762473).
- Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPDIndependent statistical analysis of A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Copper Histidine Therapy for Menkes Diseases: Complete Statistical AnalysisIndependent statistical analysis of Copper Histidine Therapy for Menkes Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001262).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662060).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).
- Coronary MDCTA With Iopamidol Injection 370: Complete Statistical AnalysisIndependent statistical analysis of Coronary MDCTA With Iopamidol Injection 370: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00558792).
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: Complete Statistical AnalysisIndependent statistical analysis of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227980).